Reciprocal repression between Fgf8 and miR-133 regulates cardiac induction through Bmp2 signaling

Area of Science:

• Developmental Biology
• Molecular Biology
• Genetics

Background:

• Early cardiac specification relies on intricate signaling pathways.
• Fibroblast Growth Factor 8 (Fgf8) and Bone Morphogenetic Protein 2 (Bmp2) signaling are critical for heart development.
• MicroRNAs (miRNAs) play regulatory roles in developmental processes.

Purpose of the Study:

• To investigate the role of miR-130 in early cardiac specification.
• To elucidate the regulatory mechanisms of Fgf8-Bmp2 feedback loops.
• To explore the involvement of miR-133 in cardiac induction and its relationship with Fgf8 and Bmp2 signaling.

Main Methods:

• Analysis of miRNA expression patterns during early cardiac specification.
• Experimental manipulation of miR-130 and miR-133 levels (overexpression and loss-of-function).
• Assessment of downstream gene expression, including cardiac markers (Nkx-2.5, Gata4) and signaling pathway components (Fgf8, Bmp2, Erk1/2).

Main Results:

• miR-130 targets Erk1/2 (Mapk1) and regulates a negative Fgf8-Bmp2 feedback loop.
• miR-133 is expressed in precardiac areas and its expression pattern correlates with FGFR1.
• miR-133 overexpression decreases Fgf8 but increases Bmp2 and cardiac markers; Fgf8 depletion increases miR-133; Bmp2 upregulates miR-133.

Conclusions:

• miR-130 is essential for controlling Fgf8 signaling via Bmp2, regulating early cardiac specification.
• miR-133 is also a key regulator in cardiac induction, modulating the crosstalk between Fgf8 and Bmp2 signaling by influencing the Fgf8/ERK pathway.
• Both miR-130 and miR-133 are crucial for precise cardiac development through intricate feedback mechanisms.